$10.73
-0.17-1.56%
最終更新: Oct 5, 12:55 PM
$11.05
0.151.38%
Benzinga
Benzinga
Benzinga
月曜日, 10 05
Benzinga
© 2026 Benzinga | All Rights Reserved
Corvus Pharmaceuticals (CRVS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.17 | $-0.15 | $-0.14 | $-0.14 |
| Actual | $-0.19 | $-0.15 | $-0.15 | $-0.12 |
| Surprise | -11.8% | 0.00% | -7.14% | +14.3% |
| Revenue | ||||
| Estimate | — | $620000 | $620000 | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | -100.0% | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.22 | $-0.22 | $-0.23 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.19 | $-0.17 | -11.8 % |
| Q1 | May 7, 2026 | $-0.15 | $-0.15 | 0.00 % |
| Q4 | Mar 12, 2026 | $-0.15 | $-0.14 | -7.14 % |
| Q3 | Nov 4, 2025 | $-0.12 | $-0.14 | 14.3 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q1 | May 7, 2026 | $0 | $620.00K | -100.0 % |
| Q4 | Mar 12, 2026 | $0 | $620.00K | -100.0 % |